Please assess the completion status of the following clinical trial:

Trial Title: In Vitro Maturation (IVM) of Human Oocytes

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Each subject must be female.~2. Each subject must have an indication for COH and IVF with or without ICSI.~3. Each subject must be willing and able to provide written informed consent for the trial~4. Each subject must be 25 to ≤42 years of age at the time of signing informed consent.~5. Each subject must have a normal cervical smear result (no atypical or abnormal cells, or in case of atypical squamous or glandular cells, no signs of malignancy; corresponding to Papanicolaou \[PAP\] I or II) obtained within 12 months prior to signing informed consent must be available~Exclusion Criteria:~1. Subject with premature ovarian failure~2. Subject with endocrine abnormalities such as hyperprolactinaemia or thyroid dysfunction~3. Subject with malformation or absence of uterus~4. Subject has tested positive for Human Immunodeficiency Virus (HIV) or Hepatitis B (by local laboratory; results obtained within 1 year prior to signing ICF are considered valid).~5. Subject with contraindication or allergy/hypersensitivity to hCG, estrogen and progesterone

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 42 Years
- Healthy Volunteers: t

Study Arms:
- In vitro Maturation (Type: EXPERIMENTAL): in vitro maturation of immature oocytes

Based on this trial design, predict the completion outcome and termination type (if applicable).